High apoA-IV pre-surgical levels are related to improved insulin sensitivity after Roux-en-Y bypass surgery, which is an effective treatment for obesity and obesity-related co-morbidities, such as diabetes [22]. This evidence concerns the gene APOA4 and obesity due to melanocortin 4 receptor deficiency.